Development of a SETD2-related immune prognostic signature in clear cell renal cell carcinoma

BACKGROUND: Renal cell carcinoma (RCC) is a malignant tumor of urinary system, and clear cell RCC (ccRCC) is the major pathological subtype. A high-frequency mutation in SETD2 gene is related to the occurrence, development, and poor prognosis of RCC. OBJECTIVE: The research of immune-related genes (...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xingyuan, Xia, Zhinan, Li, Zhiyuan, Zhang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351884/
https://www.ncbi.nlm.nih.gov/pubmed/35945780
http://dx.doi.org/10.1097/MD.0000000000029561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351884/
https://www.ncbi.nlm.nih.gov/pubmed/35945780
http://dx.doi.org/10.1097/MD.0000000000029561

Ejemplares similares